Baird Melissa 4
4 · Hims & Hers Health, Inc. · Filed May 13, 2025
Insider Transaction Report
Form 4
Baird Melissa
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-05-12$2.43/sh+33,333$80,999→ 838,416 total - Exercise/Conversion
Stock Option (right to buy)
2025-05-12−33,333→ 693,795 totalExercise: $2.43Exp: 2030-05-13→ Class A Common Stock (33,333 underlying) - Sale
Class A Common Stock
2025-05-12$55.86/sh−6,801$379,872→ 817,829 total - Sale
Class A Common Stock
2025-05-12$56.80/sh−7,556$429,210→ 810,273 total - Sale
Class A Common Stock
2025-05-12$54.98/sh−13,786$757,935→ 824,630 total - Sale
Class A Common Stock
2025-05-12$57.87/sh−5,190$300,360→ 805,083 total
Footnotes (6)
- [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
- [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.